An injectable depot composition comprising: (a) a lactic acid-based polymer which has a number average molecular weight ranging from 3,000 to 10,000; (b) benzyl alcohol or benzyl benzoate as a solvent, in an amount effective to plasticize the polymer and form a gel therewith; and (c) bupivacaine.